|
|
Legal status
Application deemed to be withdrawn
| (51) | INT.CL.: (2006.01) |
A61K 45/00 A61K 35/66 A61K 38/00 A61K 38/17 A61K 38/21 A61K 38/22 A61K 48/00 A61P 7/00 A61P 9/00 A61P 35/00 A61P 43/00 |
| (11) | Number of the document | |
| (13) | Kind of document | A |
| (21) | Application number | 2003 016 |
| (22) | Date of filing the application | 2003-02-17 |
| (41) | Date of publication of the application | 2003-10-27 |
| (45) | Date of publication of patent |
| (86) | Number | PCT/US01/41412 |
| Date | 2001-07-26 |
| (87) | Number | WO 02/07777 |
| Date | 2002-01-31 |
| (30) | Number | Date | Country code |
| 60/220.844 | 2000-07-26 | US | |
| 09/912.252 | 2001-07-25 | US |
| (71) |
SCHERING AKTIENGESELLSCHAFT,
13342 Berlin,
DE
|
| (72) |
Ed CROZE, US
David VOGEL, US Dean RUSSELL-HARDE, US |
| (73) |
SCHERING AKTIENGESELLSCHAFT,
13342 Berlin,
DE
|
| (74) |
Rita LAURINAVIČIŪTĖ,
Gedimino pr. 45-6, LT-01109 Vilnius,
LT
|
| (54) | USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS |